News
Starting Alzheimer’s Treatment Earlier Increases Benefits to Patients and Society
October 7, 2026
Featured Experts: Jack M. Chapel, PhD, Bryan Tysinger, PhD, Hossein Pourmand, DPPD, MBA, Dana Goldman, PhD, Paul Aisen, MD
Research
All Research Featured Research
Journal Article
Adoption and Willingness to Pay for Emerging Dementia Therapies: Evidence From a Nationally Representative Survey
September 25, 2026
Featured Experts: J. Felipe Montano-Campos, PhD, Julie Zissimopoulos, PhD, Mireille Jacobson, PhD, Bryan Tysinger, PhD, Geoffrey Joyce, PhD
News
Older Adults Have Strong Interest in Dementia Vaccine, Survey Finds
September 21, 2026
Featured Experts: J. Felipe Montano-Campos, PhD, Geoffrey Joyce, PhD, Julie Zissimopoulos, PhD
Perspective
Alzheimer’s Science Is Advancing: California Can Keep It Moving With the ASAP Act
September 16, 2026
Featured Experts: Joseph Grogan, JD
Comment Letter
Comments to CMS on Payment for Physician-Patient Clinical Trial Discussions
September 15, 2026
Featured Experts: Mireille Jacobson, PhD, Sidra Haye, PhD, Phyllis Barkman Ferrell, DrPH, MBA, Dana Goldman, PhD
Issue Brief
Fixing the Funnel: Stakeholder Insights on Alzheimer’s Disease Trial Recruitment
August 7, 2026
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Mireille Jacobson, PhD, Desi Peneva, MS
Perspective
Alzheimer’s Drugs Deserve a Second Opinion
July 13, 2026
Featured Experts: Paul Aisen, MD, Joseph Grogan, JD
News
Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds
June 24, 2026
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD, Johanna Thunell, PhD
Perspective
Improving Clinical Trials Reporting in Medicare Claims
June 12, 2026
Featured Experts: Sidra Haye, PhD, Mireille Jacobson, PhD
Evidence Base
Alzheimer’s Biomarkers May Vary Across Populations—Complicating Trial Eligibility
May 21, 2026
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA
News
Schaeffer Research Featured in Special Journal Issue on Alzheimer’s Care and Caregiving
April 7, 2026
Featured Experts: Julie Zissimopoulos, PhD
Perspective
Why Widespread Testing for Alzheimer’s Is Essential
April 6, 2026
Featured Experts: Dana Goldman, PhD
Evidence Base
What Nearly 1,000 Studies Reveal About Alzheimer’s Clinical Trial Recruitment
March 18, 2026
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA
Journal Article
Evaluating Evidence-Based Recruitment Strategies for Alzheimer’s Disease and Related Dementias Clinical Trial Research: A Literature Review
March 16, 2026
Featured Experts: Mireille Jacobson, PhD, Desi Peneva, MS, Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Rema Raman, PhD, Paul Aisen, MD, Dana Goldman, PhD
News
Can We Prevent Alzheimer’s Disease Within a Decade?
March 5, 2026
Featured Experts: Paul Aisen, MD, Dana Goldman, PhD
News
USC Initiative Awards Funding to Test AI-Driven Strategies to Accelerate Alzheimer’s Clinical Trials
January 20, 2026
Featured Experts: Dana Goldman, PhD, Paul Aisen, MD
Data Visualization
How Medical Costs for People with Dementia Are Changing Over Time and Across the U.S.
January 15, 2026
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD